MoonLake Immunotherapeutics (MLTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

MoonLake Immunotherapeutics (MLTX) Company Statistics | The Fly

MoonLake Immunotherapeutics

· MLTX

Dashboard

Financials

Ratios

Valuation

Statistics

974.472 M

+2.18%

General

Market Cap: $974.47M
Enterprise Value: $607.78M
Shares Outstanding: 82,630,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -45.94%
ROE: -82.68%
ROIC: -50.65%
Current Ratio: 12.56
Debt-to-Equity: 0.24
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.08
P/S: —
P/FCF: —
P/B: 2.30
EV/EBITDA: -2.42

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $266.74M
Operating Income: -$268.34M
Net Profit: -$263.67M

Balance Sheet

Cash and Equivalents: $477.91M
Working Capital: $524.65M
Total Assets: $573.95M
Net Debt: -$376.37M
Total Liabilities: $145.75M
Total Equity: $428.2M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$225.18M
Cash Flow from Investing: $58.91M
Cash Flow from Financing: $338.14M
Free Cash Flow: -$225.18M
Capital Expenditures: $0